Metagenomic next-generation sequencing for diagnosis of fatal Balamuthia amoebic encephalitis

Lixia Qin,Yaqin Xiang,Ziwei Wu,Hainan Zhang,Xiaomei Wu,Qihua Chen
DOI: https://doi.org/10.1016/j.meegid.2024.105570
IF: 4.393
2024-02-21
Infection Genetics and Evolution
Abstract:Introduction Balamuthia amoebic encephalitis (BAE), caused by Balamuthia mandrillaris , is a rare and life-threatening infectious disease with no specific and effective treatments available. The diagnosis of BAE at an early stage is difficult because of the non-specific clinical manifestations and neuroimaging. Case description A 52-year-old male patient, who had no previous history of skin lesions, presented to the emergency department with an acute headache, walking difficulties, and disturbance of consciousness. The patient underwent a series of examinations, including regular cerebrospinal fluid (CSF) studies and magnetic resonance imaging, and tuberculous meningoencephalitis was suspected. Despite being treated with anti-TB drugs, no clinical improvement was observed in the patient. Following corticosteroid therapy, the patient developed a rapid deterioration in consciousness with dilated pupils. Metagenomic next-generation sequencing (mNGS) revealed an unexpected central nervous system (CNS) amoebic infection, and the patient died soon after the confirmed diagnosis. Conclusion This study highlights the application of mNGS for the diagnosis of patients with suspected encephalitis or meningitis, especially those caused by rare opportunistic infections.
infectious diseases
What problem does this paper attempt to address?